Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 266.16M
March 31, 2026 266.16M
December 31, 2025 266.14M
September 30, 2025 266.14M
June 30, 2025 266.14M
March 31, 2025 266.14M
December 31, 2024 266.13M
September 30, 2024 266.12M
June 30, 2024 266.05M
March 31, 2024 266.00M
December 31, 2023 174.10M
September 30, 2023 173.94M
June 30, 2023 173.68M
March 31, 2023 173.07M
December 31, 2022 173.07M
Date Value
September 30, 2022 91.13M
June 30, 2022 90.91M
March 31, 2022 90.91M
December 31, 2021 90.91M
September 30, 2021 72.92M
June 30, 2021 72.74M
March 31, 2021 70.52M
December 31, 2020 52.35M
September 30, 2020 52.30M
June 30, 2020 52.25M
March 31, 2020 52.25M
December 31, 2019 44.98M
September 30, 2019 44.98M
June 30, 2019 44.98M
March 31, 2019 40.15M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Bicycle Therapeutics Plc 50.38M
Biodexa Pharmaceuticals Plc --
argenx SE --
NuCana Plc 4.310M
Mereo BioPharma Group Plc 159.62M